iBio
在场
iBio 是一家在股票代码 IBIO (US) 下上市的公司。
高管
查看带有其 9 名主要高管的组织结构图
iBio 搜索最多的简介
- Martin Brenner, Chief Executive Officer and Chief Scientific Offic...
- Alexandra Kropotova, Director
- Eef Schimmelpennink, Director
高管在iBio变化
- Kristi Sarno已作为Senior Vice President of Business Development加入公司 (新闻发布的2024八月13号).
创建提醒
跟踪 iBio 的高管变动
药店
iBio 拥有 1,842 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Stemtech and Seacret Direct have announced they will merge (公布2024十一月22号)..
- BeiGene将改名为BeOne Medicines。 (公布2024十一月15号).
- GlycoMimetics and Crescent Biopharma have announced they will merge (公布2024十一月15号)..
药店 行业的其他推荐联系人
消息
iBio 的最新新闻稿
- iBio Reports Fiscal First Quarter 2025 Financial Results
- iBio and AstralBio Provide Update on Myostatin Program for Obesity
- iBio Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
- iBio to Participate in Upcoming Investor Conferences
- iBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business Development
- iBio Closes Sale of Manufacturing Facility in Texas
- iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate Update
- iBio and AstralBio Announce Transformative AI drug discovery Collaboration to Rapidly Develop Novel Antibodies for Obesity and Cardiometabolic Diseases
- Press Releases
- iBio Announces $15.0 Million Private Placement
- View more press releases Close
关于 iBio 的社交媒体
保持联系
通过电子邮件联系联系该企业高管，包括 Eef Schimmelpennink 
